Industrial Doctorate Centre: Systems Approaches to Biomedical Science

拟议中的牛津生物医学科学系统方法工业博士学位的目标是确保英国在制药、生物医学、生物技术和与生物医学相关的IT领域拥有强大的未来创新者和研究领导者的管道。它将建立在牛津现有的两个技术研究中心(生命科学接口和系统生物学)和我们现有的工业博士试点计划的跨学科科学培训的记录和模式的基础上，提供针对每个学生的需要的全面的工业研究培训计划，并将与来自EPSRC与医疗保健相关课程范围内的国际领先的工业合作伙伴和学术团体进行接触。IDC项目的毕业生将在授课项目和以行业为基础的研究项目中广泛接触其研究的行业背景。这将使他们在项目管理、策略规划、领导力、团队合作、商业意识和解决问题方面发展所需的技能，将基础和医学科学的创新转化为商业产品开发。这项计划得到了相关行业(制药、生物医学和成像、与健康相关的信息技术和生物技术)的大力支持。支持这一提议的13家公司是：GE Healthcare(GE Healthcare，负责技术的副总裁Jonathan Allis博士)；GSK(GSK临床成像中心成像副总裁兼负责人Paul Matthews教授)；阿斯利康(高级科学和技术实验室主任Andy Hargreaves博士)；罗氏(集团研究全球负责人Bryn Roberts博士)；诺华(结构科学部门单位负责人Ulrich Hummel博士)；辉瑞(Pfizer)(Ian Machin，疼痛发现生物学总监)；西门子分子成像(Jrme Declerck博士，科学与技术主管)，微软研究(Stephen Emmott教授，外部研究主管)，飞利浦(Lothar Spies博士，数字成像主管)，富士通欧洲实验室(Ross Nobes博士，计算生物学负责人)，UCB Celltech(Jiye Shih博士)，Inhibox(Paul Finn博士)和Summit(Richard Vickers，药物发现)。每一家公司将向国际数据中心提供的支持程度的全部细节见所附的上述代表的支持信。其中几家公司将直接参与拟议的IDC的教学计划。如果英国要保持在生物技术、生物医学和制药领域的领先地位，生产这些工业科学家是至关重要的。目前的经济状况给这些部门带来了财务压力，但未来的创新和产品开发需要从现在开始对这些未来几代科学家的培训。因此，EPSRC的支持至关重要。同样，拟议的培训和研究方案的跨学科性质要求培训方案中必须有足够多的学生能够相互支持和学习，而国际数据中心的总体目标根本不能通过标准的博士培训路线来实现。

The goal of the proposed Oxford Industrial Doctorate in Systems Approaches to Biomedical Science is to ensure that the UK has a strong pipeline of future innovators and research leaders in the pharmaceutical, biomedical, biotechnology, and biomedically-related IT sectors. It will build on the track record and model of inter-disciplinary scientific training of the two existing DTCs in Oxford (at the Life Sciences Interface and in Systems Biology), and of our existing Industrial Doctorate pilot scheme, to provide a comprehensive industrial research training programme, tailored to the needs of each individual student, and will engage with internationally leading industrial partners and academic groups drawn from across the spectrum of EPSRC's healthcare-related programmes. Graduates from the IDC programme will receive extensive exposure to the industrial context of their research in both the taught programme and in their industry-based research projects. This will allow them to develop the skills in project management, strategic planning, leadership, team working, commercial awareness, and problem solving that will be required to translate innovations in basic and medical science into commercial product development.The proposal has very strong support from across the relevant industry sectors (pharmaceutical, biomedical and imaging, health-related IT and biotechnology). The 13 companies supporting this proposal are: GE Healthcare (Dr Jonathan Allis, Vice President for Technology); GSK (Professor Paul Matthews, Vice President, Imaging and Head, GSK Clinical Imaging Centre); AstraZeneca (Dr Andy Hargreaves, Director, Advanced Science and Technology Lab); Roche (Dr Bryn Roberts, Global Head of Group Research); Novartis (Dr Ulrich Hummel, Unit Head, Structural Sciences); Pfizer (Ian Machin, Director Pain Discovery Biology); Siemens Molecular Imaging (Dr. Jrme Declerck, Head of Science and Technology), Microsoft Research (Prof Stephen Emmott , Director of External Research), Philips (Dr Lothar Spies, Head of Digital Imaging); Fujitsu European Laboratory (Dr Ross Nobes, Head of Computational Biology), UCB Celltech (Dr Jiye Shi); Inhibox (Dr Paul Finn); and Summit (Richard Vickers, Drug Discovery). Full details of the levels of support to be provided to the IDC by each of these companies are given in the attached letters of support from each of the representatives listed above. Several of these companies will be directly involved in the teaching programme of the proposed IDC.Producing these industrial scientists is of paramount importance if the UK is to remain at the forefront of the biotechnology, biomedical and pharmaceutical sectors. Current economic conditions are resulting in financial pressures across these sectors, but future innovation and product development requires that the training of these future generations of scientists commences now. EPSRC support is therefore vital. Similarly, the interdisciplinary nature of the proposed training and research programmes necessitate a critical mass of students within the training programme who can support and learn from one another, and the overall goals of the IDC simply could not be met by the standard PhD training route.